Literature DB >> 25611593

Increased coupling of caveolin-1 and estrogen receptor α contributes to the fragile X syndrome.

Qi Yang1, Le Yang, Kun Zhang, Yan-Yan Guo, Shui-Bing Liu, Yu-Mei Wu, Xiao-Qiang Li, Qian Song, Min Zhuo, Ming-Gao Zhao.   

Abstract

OBJECTIVE: Fragile X syndrome (FXS) is a form of inherited mental retardation in humans that results from expansion of a CGG repeat in the FMR1 gene. Interaction between estrogen receptor (ER) and lipid raft caveolae is critical for the estrogen signaling. Here, we tested the hypothesis that impaired ER-caveolae coupling contributes to the mental retardation of FXS.
METHODS: Fmr1 knockout (KO) mouse was used as the model of FXS. Multiple techniques were performed including primary neuronal culture, short hairpin RNA (shRNA) interference, Western blot, electrophysiological recording, RNA-binding protein immunoprecipitation, reverse transcriptase polymerase chain reaction, and behavioral tests.
RESULTS: In this study, we report that GluA1 surface expression and phosphorylation induced by 17β-estradiol (E2) were impaired in the Fmr1 KO neurons. The E2-mediated facilitation of long-term potentiation and fear memory was impaired in the anterior cingulate cortex of Fmr1 KO mice. The increased coupling of caveolin-1 (CAV1) and the membrane estrogen receptor ERα under basal conditions contributed to the impairment of ER signaling in Fmr1 KO neurons. FMRP (fragile X mental retardation protein) interacted with CAV1 mRNA, and knockdown of CAV1 with shRNA rescued the synaptic GluA1 delivery, plasticity, and memory in Fmr1 KO mice.
INTERPRETATION: This is the first demonstration that the coupling between ERα and lipid raft CAV1 is critical for membrane ER signaling in synaptic plasticity. Therefore, increased coupling of CAV1 and ERα may elucidate a critical abnormal mechanism of FXS.
© 2015 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25611593     DOI: 10.1002/ana.24358

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

Review 1.  Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  J Pharmacol Exp Ther       Date:  2016-10-27       Impact factor: 4.030

2.  CB1 agonism prolongs therapeutic window for hormone replacement in ovariectomized mice.

Authors:  Kun Zhang; Qi Yang; Le Yang; Yan-Jiao Li; Xin-Shang Wang; Yu-Jiao Li; Rui-Li Dang; Shao-Yu Guan; Yan-Yan Guo; Ting Sun; Yu-Mei Wu; An Liu; Yan Zhang; Shui-Bing Liu; Ming-Gao Zhao
Journal:  J Clin Invest       Date:  2019-05-06       Impact factor: 14.808

Review 3.  From embryonic development to human diseases: The functional role of caveolae/caveolin.

Authors:  Jihee Sohn; Rachel M Brick; Rocky S Tuan
Journal:  Birth Defects Res C Embryo Today       Date:  2016-03-17

Review 4.  Cooperation of Genomic and Rapid Nongenomic Actions of Estrogens in Synaptic Plasticity.

Authors:  Yu-Jie Lai; Dan Yu; John H Zhang; Guo-Jun Chen
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

5.  Of Men and Mice: Modeling the Fragile X Syndrome.

Authors:  Regina Dahlhaus
Journal:  Front Mol Neurosci       Date:  2018-03-15       Impact factor: 5.639

6.  Imbalance between Glutamate and GABA in Fmr1 Knockout Astrocytes Influences Neuronal Development.

Authors:  Lu Wang; Yan Wang; Shimeng Zhou; Liukun Yang; Qixin Shi; Yujiao Li; Kun Zhang; Le Yang; Minggao Zhao; Qi Yang
Journal:  Genes (Basel)       Date:  2016-08-10       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.